News

JetBlue Airways (NASDAQ: JBLU) stock got a big upgrade from J.P. Morgan analysts last Wednesday. Less than 24 hours later, however, Fitch -- one of the three major credit rating agencies -- cut the

Throughout 2020, tech stocks have dominated discussion within the investment community. But when it comes to high-growth potential, don't discount cannabis.

There's no question that expectations got

Back in 1993, when drugmaker Amarin's (NASDAQ: AMRN) shares first hit the market, it might have cost you $1,425 to buy one share (adjusted for splits). Go forward a few decades, and that one share

Five years ago, Elon Musk had a dream.

Rather than just build space rockets to carry other companies' satellites into orbit -- leaving SpaceX's business dependent upon the demand of third parties --

Electric vehicle pioneer Tesla (NASDAQ: TSLA) is attempting to revolutionize the automobile industry, and with visionary CEO Elon Musk at the helm, it looks to have a bright future in a fast-growing

Stocks of coronavirus vaccine candidate developers have been on fire this year. If you invested in a balanced portfolio consisting of the five most prominent COVID-19 vaccine developers in the

Over the past 10 years, pharmaceutical stocks have consistently outperformed major indices, with the Dow Jones US Pharmaceutical & Biotechnology Index up nearly 202% over that time period compared

If there's one thing Warren Buffett will never ever invest in, it's bitcoin -- or any other cryptocurrency. He's called it "rat poison squared," a "mirage," and a "gambling device."

But if there's

If you've worked for many years and are reaching the age when many of your peers are gearing up to retire, then you may be thinking about that milestone as well. But retiring requires careful

Over the course of the past decade, investors who put their money to work in the vaunted FAANG stocks -- Facebook, Amazon (NASDAQ: AMZN), Apple, Netflix, and Alphabet -- have beaten the broader

Four coronavirus vaccine candidates have advanced to late-stage clinical trials in the U.S., and another should begin late-stage testing soon. One main purpose of these clinical studies is to

Sure, it takes money to make money. However, that adage scares away some people who don't think they have enough money to even begin investing in stocks.

The reality is that you can get started

There's no question that growth stocks are getting all the attention on Wall Street right now. But when push comes to shove, growth stocks have historically taken a back seat to dividend stocks over

It's not surprising that several of the biggest drugmakers in the world have emerged as leaders in the race to develop a coronavirus vaccine. After all, they have vast resources. Some developed

Just in case it may have somehow slipped your mind amid the barrage of news coverage, ads, and tweets, there's a political election coming up this November. The differences between the candidates

Robinhood has become an incredibly popular brokerage choice for investors,in large part due to its ease of use and the fact it works hard to make investing more accessible and more fun. Not

Morgan Stanley's (NYSE: MS) acquisition of Eaton Vance (NYSE: EV) is the bank's second big move of 2020, after it acquired E*Trade earlier in the year. Morgan Stanley has spent $20 billion combined

Investing in 2020 has been quite the adventure -- and there's still 2-1/2 months to go before we close out the year. Thus far, we've witnessed a record-breaking tumble of 34% in the S&P 500 that

Curaleaf Holdings (OTC: CURLF) has had a good year, and it's likely to get better once November rolls around. Shares of the Massachusetts cannabis company are up more than 41% year to date, and

The clinical trial of Johnson & Johnson's (NYSE: JNJ) COVID-19 vaccine candidate has been paused due to an unexplained illness in a study participant, according to an article published by STAT on

Entertainment powerhouse Walt Disney (NYSE: DIS) will soon look a bit different from an investor's perspective. The company just announced a sweeping reorganization of its media and entertainment

Williams-Sonoma (NYSE: WSM) announced that its board of directors has elected to increase its quarterly dividend. The new payout will be $0.53 per share, which is just over 10% higher than the last

Are Micron Technology (NASDAQ: MU) shares about to rise by nearly 20%? Analyst Sidney Ho of Deutsche Bank thinks so; he upgraded his recommendation on the stock from neutral to buy, with a $60 per

Goldman Sachs (NYSE: GS) might trim the fiscal goals it set for itself earlier this year due to weaker-than-expected results, according to an article published Monday by Reuters.

Citing "analysts

Sorrento Therapeutics (NASDAQ: SRNE) has added another arrow to its COVID-19 quiver. The biotech licensed an adipose-derived mesenchymal stem cell (MSC) treatment from Personalized Stem Cells for